Citation: | WANG Yan, ZOU Huiling, GANG Qiang, SUN Yu. Value of miRNA-93 in early diagnosis of patients with type 2 diabetes mellitus complicated with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(18): 111-115. DOI: 10.7619/jcmp.20212960 |
[1] |
LI Y, TENG D, SHI X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997.
|
[2] |
AHMAD M I, SHAPIRO M D. Preventing diabetes and atherosclerosis in the cardiometabolic syndrome[J]. Curr Atheroscler Rep, 2021, 23(4): 16. doi: 10.1007/s11883-021-00913-8
|
[3] |
GABA P, GERSH B J, ALI Z A, et al. Complete versus incomplete coronary revascularization: definitions, assessment and outcomes[J]. Nat Rev Cardiol, 2021, 18(3): 155-168. doi: 10.1038/s41569-020-00457-5
|
[4] |
LIU J, WU J D, LI L B, et al. The role of exosomal non-coding RNAs in coronary artery disease[J]. Front Pharmacol, 2020, 11: 603104. doi: 10.3389/fphar.2020.603104
|
[5] |
RABER I, MCCARTHY C P, JANUZZI J L. A test in context: interpretation of high-sensitivity cardiac troponin assays in different clinical settings[J]. J Am Coll Cardiol, 2021, 77(10): 1357-1367. doi: 10.1016/j.jacc.2021.01.011
|
[6] |
SOLARO C R, SOLARO R J. Implications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders[J]. J Mol Cell Cardiol, 2020, 143: 145-158. doi: 10.1016/j.yjmcc.2020.05.010
|
[7] |
ZHANG L, DING H, ZHANG Y, et al. Circulating MicroRNAs: biogenesis and clinical significance in acute myocardial infarction[J]. Front Physiol, 2020, 11: 1088. doi: 10.3389/fphys.2020.01088
|
[8] |
ALINA I S, MIRUNA-MIHAELA M, NICOLETA-MONICA P F, et al. MicroRNAs in Acute ST Elevation Myocardial Infarction-A New Tool for Diagnosis and Prognosis: Therapeutic Implications[J]. Int J Mol Sci, 2021, 22(9): 4799-4818. doi: 10.3390/ijms22094799
|
[9] |
ZOU H L, WANG Y, GANG Q, et al. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy[J]. Graefes Arch Clin Exp Ophthalmol, 2017, 255(6): 1159-1166. doi: 10.1007/s00417-017-3638-5
|
[10] |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志, 2019, 47(10): 766-783. https://www.cnki.com.cn/Article/CJFDTOTAL-GWXX201504001.htm
|
[11] |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 非ST段抬高型急性冠状动脉综合征诊断和治疗指南(2016)[J]. 中华心血管病杂志, 2017, 45(5): 359-376. doi: 10.3760/cma.j.issn.0253-3758.2017.05.003
|
[12] |
DZHOYASHVILI N A, EFIMENKO A Y, KOCHEGURA T N, et al. Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2[J]. J Transl Med, 2014, 12: 337. doi: 10.1186/s12967-014-0337-4
|
[13] |
LIU J, JIANG M, DENG S, et al. miR-93-5p-containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage[J]. Mol Ther Nucleic Acids, 2018, 11: 103-115. doi: 10.1016/j.omtn.2018.01.010
|
[14] |
NAZARI-SHAFTI T Z, EXARCHOS V, BIEFER H R C, et al. MicroRNA mediated cardioprotection - is there a path to clinical translation[J]. Front Bioeng Biotechnol, 2020, 8: 149. doi: 10.3389/fbioe.2020.00149
|
[15] |
MORI M A, LUDWIG R G, GARCIA-MARTIN R, et al. Extracellular miRNAs: from biomarkers to mediators of physiology and disease[J]. Cell Metab, 2019, 30(4): 656-673. doi: 10.1016/j.cmet.2019.07.011
|
[16] |
MA Y, PAN C, TANG X, et al. MicroRNA-200a represses myocardial infarction-related cell death and inflammation by targeting the Keap1/Nrf2 and β-catenin pathways[J]. Hellenic J Cardiol, 2021, 62(2): 139-148. doi: 10.1016/j.hjc.2020.10.006
|
[17] |
SHI H, SUN H, LI J, et al. Systematic analysis of lncRNA and microRNA dynamic features reveals diagnostic and prognostic biomarkers of myocardial infarction[J]. Aging: Albany NY, 2020, 12(1): 945-964. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM31927529
|
[18] |
ZHONG Z, WU H, ZHONG W, et al. Expression profiling and bioinformatics analysis of circulating microRNAs in patients with acute myocardial infarction[J]. J Clin Lab Anal, 2020, 34(3): e23099. doi: 10.1002/jcla.23099
|
[19] |
LIU J W, JIANG M, DENG S Q, et al. miR-93-5p-containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage[J]. Mol Ther Nucleic Acids, 2018, 11: 103-115. doi: 10.1016/j.omtn.2018.01.010
|
[20] |
SOHRABIFAR N, GHADERIAN S M H, VAKILI H, et al. MicroRNA-copy number variations in coronary artery disease patients with or without type 2 diabetes mellitus[J]. Arch Physiol Biochem, 2019: 1-7. doi: 10.1080/13813455.2019.1651340
|